Cargando…
Nigericin is a potent inhibitor of the early stage of vaccinia virus replication
Poxviruses remain a significant public health concern due to their potential use as bioterrorist agents and the spread of animal borne poxviruses, such as monkeypox virus, to humans. Thus, the identification of small molecule inhibitors of poxvirus replication is warranted. Vaccinia virus is the pro...
Autores principales: | Myskiw, Chad, Piper, Jessica, Huzarewich, Rhiannon, Booth, Tim F., Cao, Jingxin, He, Runtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533862/ https://www.ncbi.nlm.nih.gov/pubmed/20951746 http://dx.doi.org/10.1016/j.antiviral.2010.10.001 |
Ejemplares similares
-
Approach to nigericin derivatives and their therapeutic potential
por: Sahu, Amit Kumar, et al.
Publicado: (2020) -
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
por: Czub, Markus, et al.
Publicado: (2005) -
Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid
por: He, Runtao, et al.
Publicado: (2004) -
Nigericin Promotes NLRP3-Independent Bacterial Killing in Macrophages
por: Armstrong, Heather, et al.
Publicado: (2019) -
A potassium ionophore (Nigericin) inhibits stimulation of human lymphocytes by mitogens
Publicado: (1978)